corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 9591

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Chappell SC.
Among top 100 companies: 26 generic firms show aggregate 17% growth
Pharmacy Times 1987 Oct; 53:63-64, 67-69


Abstract:

Statistics from the National Prescription Audit comparing prescription volume for the first half of 1987 with volume for the initial 6 months of 1986 are presented. The comparison showed the same disparate pattern between new and refill prescription trends. Although the width of the disparity was not as significant as that noted in the full yr 1986/1985 the trends continue to be in opposite directions; new prescriptions have grown by 3%, while refills have declined by only 1%. Pharmacist brand choice decisions were noted in some 25% of all new prescriptions dispensed in the first 6 months of 1987. The corresponding figure for the first half of 1986 was 24%. The trend represents an increase in the share of the market controlled by pharmacists. January to June 1987 data list 26 generic houses among the top 100 companies. Updated top 200 product lists during the first 6 months of 1987 are presented in a table.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909